Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq®) will be available in Hong Kong from St. Teresa's Hospital by ...
AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...
The Brighterside of News on MSN19h
Common herb restores memory and reduces inflammation for Alzheimer's patientsAlzheimer’s disease is the most common cause of dementia and the sixth leading cause of death in the United States. It ...
This unexpected early warning sign relates to a change in sensory perception, specifically your sense of smell. A declining ...
Discover how drinking black coffee can boost your mood, fight cancer, reduce disease risk, and improve overall health in ...
Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...
News-Medical.Net on MSN18h
Portable system detects mild cognitive impairment in older adultsMild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback